The E in ESG: Activity-Based Strategies Can Address Climate Impact Of Clinical Research

14 Jun 2023

A partnership approach is required to reduce greenhouse gas emissions generated by pharma clinical studies. That is the advice in this guest contribution by the Sustainable Healthcare Coalition and Johnson & Johnson’s Janssen company to In Vivo’s rolling series on issues in sustainability for healthcare product manufacturers and providers.

Pharma companies view clinical trials as playing a big part towards achieving the overriding goal of improving patients’ health. But of late, there has been a collective rise in awareness that our work often has an environmental impact that we can help mitigate.

In the process of serving and supporting patients, the combined healthcare sector produces up to 2.6 billion tons of carbon...